NanoViricides Says Clinical Lead Drug NV-387 Shows Strong Activity Against Measles Virus In Humanized Animal Model; Says NV-387 Can Now Be Made Available For Emergency Use Application In Measles Patients
Author: Benzinga Newsdesk | October 20, 2025 08:47am